ClinicalTrials.gov
ClinicalTrials.gov Menu

Hämeenlinna Metabolic Syndrome Research Program: Surrogate Indicators for Atherosclerosis (HMS-02)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01119404
Recruitment Status : Unknown
Verified May 2010 by Central Hospital of Kanta-Hame.
Recruitment status was:  Recruiting
First Posted : May 7, 2010
Last Update Posted : May 11, 2010
Sponsor:
Collaborators:
Linnan Klinikka Oy
Mehiläinen Hämeenlinna, Finland
Finnish Red Cross
Information provided by:
Central Hospital of Kanta-Hame